To further delineate the expression of EIF4EBP1 in malignant gliomas including IDH-wildtype and IDH-mutant tumors, we determined the levels of EIF4EBP1 in additional publically available glioma datasets and investigated its association with common genetic alterations as well as EIF4EBP1 gene copy number alteration and promoter methylation. The gene discussed is EIF4EBP1; the disease is central nervous system cancer.